ITGAX and breast carcinoma: Apart from the mouse model, it was further explored whether PD-L1 expression correlated to a pro-tumoral “M2”-like (CD163+) TAM phenotype or an anti-tumoral CD11c+ macrophage/dendritic cell phenotype in breast cancer patient samples.